Bolt Biotherapeutics, Inc. (BOLT)
6.54
+0.16
(+2.51%)
USD |
NASDAQ |
Nov 06, 16:00
6.50
-0.04
(-0.61%)
After-Hours: 20:00
Bolt Biotherapeutics Research and Development Expense (Annual) : 27.04M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 27.04M |
| December 31, 2024 | 55.29M |
| December 31, 2023 | 59.66M |
| December 31, 2022 | 68.23M |
| Date | Value |
|---|---|
| December 31, 2021 | 71.98M |
| December 31, 2020 | 37.85M |
| December 31, 2019 | 24.67M |
| December 31, 2018 | 9.118M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Caribou Biosciences, Inc. | 109.44M |
| Arrowhead Pharmaceuticals, Inc. | 585.26M |
| Oncolytics Biotech, Inc. | 13.31M |
| Sangamo Therapeutics, Inc. | 112.67M |
| Sarepta Therapeutics, Inc. | 1.493B |